The presence of ASPL-TFE3 fusion transcripts was assessed by reverse transcriptase polymerase chain reaction.     ///    "The high expression of MET in ASPL-TFE3 (+) ASPS may further support the potential role of targeted agents against MET in this rare, chemoresistant tumor.. "